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Reverse immunogenetic approaches attempt to optimize the selection of candidate
epitopes, and thus minimize the experimental effort needed to identify new epitopes.
When predicting cytotoxic Tcell epitopes, the main focus has been on the highly specific
MHC class I binding event. Methods have also been developed for predicting the
antigen-processing steps preceding MHC class I binding, including proteasomal
cleavage and transporter associated with antigen processing (TAP) transport efficiency.
Here, we use a dataset obtained from the SYFPEITHI database to show that a method
integrating predictions of MHC class I binding affinity, TAP transport efficiency, and C-
terminal proteasomal cleavage outperforms any of the individual methods. Using an
independent evaluation dataset of HIV epitopes from the Los Alamos database, the
validity of the integrated method is confirmed. The performance of the integrated
method is found to be significantly higher than that of the two publicly available
prediction methods BIMAS and SYFPEITHI. To identify 85% of the epitopes in the HIV
dataset, 9% and 10% of all possible nonamers in the HIV proteins must be tested when
using the BIMAS and SYFPEITHI methods, respectively, for the selection of candidate
epitopes. This number is reduced to 7% when using the integrated method. In practical
terms, this means that the experimental effort needed to identify an epitope in a
hypothetical protein with 85% probability is reduced by 20–30% when using the
integrated method.
The method is available at http://www.cbs.dtu.dk/services/NetCTL. Supplementary
material is available at http://www.cbs.dtu.dk/suppl/immunology/CTL.php.
Introduction
For the cytotoxic Tcells (CTL) of the immune system to
discriminate between healthy cells and infected cells, all
nucleated cells present a selection of the peptides
contained intheir proteinsonthecellsurfaceincomplex
with MHC class I. However, only a small fraction of the
peptides in a pathogen proteome are able to elicit a CTL
response. This is mainly due to the selectivity in the
antigen-processing steps preceding the CTL response.
For each MHC class I allele, only 1 out of 2000 potential
peptides will be immunodominant [1]. A prerequisite
for the induction of a CTL response is the generation of
peptides from their precursor polypeptides. The major
cytosolic protease associated with the generation of
antigenic peptides – in particular the C-terminal end of
the peptides – is the proteasome [2–6]. After protea-
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terminal end by other peptidases in the cytosol [7]. The
next step is the translocation of the peptides from the
cytosol to the interior of the ER. This transport is
facilitated by binding of the peptides toTAP. Once inside
the ER, further N-terminal trimming of the peptides may
occur [5, 8], aswell asbinding of some of the peptides to
MHC class I. After binding, the MHC class I:peptide
complexis transported tothesurface of the cell, where it
may be recognized by CTL. The most restrictive step
involved in antigen presentation is the binding to MHC
class I. It is estimated that only 1 out of 200 peptides will
bind agivenMHCclass I allelewith sufficientstrength to
elicit a CTL response [1]. However, it has previously
been shown that the proteasomal cleavage and the TAP
transport efficiency show also some degree of specificity
[9, 10].
Reliable predictions of immunogenic peptides can
minimizetheexperimentaleffortneeded toidentifynew
epitopes.Accordingly,manyattemptshavebeenmadeto
predict the outcome of the steps involved in antigen
presentation. A number of methods have been devel-
oped that very reliably predict the binding affinity of
peptides to the different MHC class I alleles [11–14].
Likewise, methods have been developed that predict the
efficiency with which peptides of arbitrarylength willbe
transported by TAP [15, 16]. Several methods have also
been developed that aim at predicting the proteasomal
cleavage pattern of proteins. One such method is
NetChop, which can be found in various versions,
trained on different types of data [17]. In this work, we
focus on NetChop C-term and NetChop 20S. NetChop C-
term has been trained on natural MHC class I ligands,
whereas NetChop 20S is trained on in vitro cleavage
data. It has previously been shown that NetChop 20S is
less accurate in predicting the C-terminal ends of
naturally occurring MHC class I ligands than NetChop
C-term 2.0 [17]. Similar results were obtained in a new
implementation of NetChop (NetChop C-term 3.0 and
NetChop 20S-3.0), where a superior performance was
obtained using a novel network training strategy and
sequence encoding scheme [18].
Combining HLA-A*0201 affinity predictions with
predictions of TAP transport efficiency has previously
been done by Peters et al. [16], and was shown to lead to
improved identification of CTL epitopes. In the same
work, they also combined HLA-A*0201 affinity predic-
tions with predictions of C-terminal cleavages by
NetChop 20S, and showed that this led to a less accurate
identification of epitopes. The analysis of Peters et al.
was, however, limited to a single MHC class I allele.
Here, we extended the analysis to include epitopes for a
large set of MHC class I alleles belonging to ten different
MHC class I supertypes [19, 20]. Further, we modeled
the proteasomal cleavage event by novel and more
reliable prediction algorithms [18]. We generated a
dataset containing 148 nonameric epitopes extracted
from the SYFPEITHI database (http://www.syf-
peithi.de, [21]). The majority of these peptides have
successfully passed the steps involved in antigen
presentation. We used this dataset to develop an
improved method for CTL epitope identification by
combining the prediction methods for MHC class I
affinity, TAP transport efficiency, and C-terminal
cleavage, and have demonstrated that the integrative
approach has a predictive performance that is superior
to predictions of MHC class I affinity alone using either
artificial neural networks (ANN) [13], BIMAS [22], or
SYFPEITHI [23]. Internal cleavage of peptides may
result in the destruction of epitopes. However, we have
foundthatpredictionofsuchinternalcleavagesitesdoes
not improve the predictability of epitopes. Finally, we
have confirmed the validity of our integrated method on
an independent dataset of HIV epitopes from the Los
Alamos database. Here, we show that the performance
of the integrated method is superior to the two publicly
available methods BIMAS [22] and SYFPEITHI [23].
Results
We defined a combined prediction score for MHC class I
affinity, TAP transport efficiency, and C-terminal
proteasomal cleavage as a weighted sum of the three
individual prediction scores. For MHC class I affinity, we
used the rescaled prediction values, as described in
Materials and methods. For TAP transport efficiency we
used the method of Peters et al. [16], and for the
proteasomalcleavageoneof thefourcleavagepredictors
described in Materials and methods. We used the SYF
1
dataset to estimate the set of weights in which the Arank
and AUC values were optimal (see Materials and
methods for a description of Arank and AUC values).
The optimal combined method was found to have
relative weights on TAP transport efficiency and C-
terminal cleavageof 0.05 and 0.1, respectively. Notethat
these weights do not directly reflect the relative
contribution of different prediction methods since the
individual methods do not give comparable output
values. Strong internal cleavage sites could destroy
potential epitopes. We therefore tested if predictions of
internal cleavage sites could contribute to the identifica-
tion of epitopes when combined with predictions of
MHC class I binding. However, we found that none of
the internal sites could improve the ability to identify
epitopes (data not shown). In Fig. 1, we show examples
of ROC and rank curves for the SYF
1 dataset (see
Materials and methods). The figure shows the perfor-
mance curves for six different prediction scoring
schemes: INT, NetMHC, TAP, NetChop3.0, NetCh-
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integrated method with relative weight on TAP and
NetChop3.0 of 0.05 and 0.1, respectively, NetMHC
represents ANN-based MHC class I affinity predictions,
NetChop3.0 and NetChop20S-3.0 are the C-terminal
cleavage predictions of NetChop C-term 3.0 and
NetChop 20S-3.0, respectively, and BIMAS is the
publicly available method for MHC peptide binding
predictions [22]. Fig. 2 gives the details of the
performance measures for the different methods and
their combinations when evaluated on the SYF
1 dataset.
Fig. 1. ROC and Rank performance curves for different
prediction methods. (A) The ROC curves. AUC is the area
under the ROC curve. (B) Rank curves. Arank is the area under
therank curve (asanexample, thearea underthe20S-3.0curve
is highlighted) as described in Materials and methods.
Predictions are made on the SYF
1 dataset. The different
prediction methods are; INT: Optimal integrated method with
relative weight on TAP transport efficiency and C-terminal
cleavage of 0.05 and 0.1, respectively. NetMHC: MHC class I
affinity by ANN, TAP: TAP transport efficiency. NetChop3.0: C-
terminal cleavage of the NetChop C-term 3.0 proteasomal
predictor. 20S-3.0: C-terminal cleavage of the NetChop 20S-3.0
predictor, and BIMAS: MHC class I binding predictor [22].
Fig.2.Predictiveperformancefordifferentpredictionmethods.
(A) AUC is the area under the ROC curve, and (B) Arank is the
area under the rank curve as described in Materials and
methods. Predictions are made on the SYF
1 dataset. The figure
shows the performance measures for each method on its own,
the optimal performance in combination with MHC class I
affinity predictions, and the optimal performance in combina-
tion with TAP transport efficiency and MHC class I affinity
predictions. The different prediction methods are; NetMHC:
MHC class I affinity by ANN, TAP: TAP transport efficiency, 20S:
C-terminal cleavage of the NetChop 20S-2.0 predictor, 20S-3.0:
C-terminal cleavage of the NetChop 20S-3.0 predictor, NetCh-
op2.0: C-terminal cleavage of the NetChop C-term 2.0 protea-
somal predictor, NetChop3.0: C-terminal cleavage of the
NetChop C-term 3.0 proteasomal predictor. BIMAS is a publicly
available MHC class I binding prediction method [22].
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aspect of using the AUC performance measure when
dealing with highly unbalanced datasets. The AUC
values for the TAP and NetChop C-term 3.0 prediction
methods are close to identical (0.79 and 0.81, see
Fig. 2A). However, looking at the curves for each
method, it is clear that the NetChop C-term 3.0 method
provides the most useful predictions. The region of the
ROC curve where the TAP predictor performs best falls
in a highly non-relevant region of the specificity. The
two curves cross at a false-positive ratio of 0.35. This
value corresponds to 35% false-positive predictions, and
having an improved prediction method only in this
specificity range is clearly irrelevant. For the Arank
measure this problem is not present since we here
explicitly focus on the high rank region only.
The results shown in Figs 1 and 2 demonstrate that
the method integrating predictions of MHC class I
affinity, TAP transport efficiency, and proteasomal
cleavage has the highest performance in terms of both
the AUC and Arank values. The individual method with
the poorest performance is that of NetChop 20S,
followed by NetChop 20S-3.0, TAP, the NetChop C-term
2.0 and NetChop C-term 3.0 methods, and MHC class I
affinity (BIMAS and NetMHC). Performing a bootstrap
experiment to determine which method has the highest
predictive performance using the Arank measure, we
found that NetMHC performs marginally better than the
BIMAS method (p=0.06). The integrated INT method,
on the other hand, has a performance on both the AUC
andArankmeasures thatis significantlyhigher than that
of both the BIMAS and NetMHC prediction methods
(p<0.01 in all comparisons).
It is striking to observethat even though the different
NetChop predictors individually have very different
predictive performance, they all achieve similar pre-
dictive performance when combined with MHC class I
affinity predictions. We see, for instance, only a
marginally higher performance of the method integrat-
ing predictions from the best proteasomal cleavage
prediction method NetChop C-term 3.0 relative to a
combined method integrating predictions from the
poorest proteasomal cleavage prediction method NetCh-
op 20S. The NetChop C-term 3.0 predictor, which has
been trained on epitope data, has been criticized for
predicting a combination of MHC class I affinity, TAP
transport efficiency, and proteasomal cleavage rather
than just proteasomal cleavage [16]. Here, we find that
the NetChop 20S-3.0 and TAP predictors can be
combined in a constructive manner with a predictive
performance significantly higher than that of the
individual predictors (AUC=0.805, Arank=0.615). This
is not the case for the NetChop C-term 3.0 predictor.
Here, the combination with TAP only leads to a minor
and insignificant improvement in the predictive perfor-
mance (AUC=0.813, Arank=0.670). However, when
combined with NetMHC and TAP, both NetChop 20S-3.0
and NetChop C-term 3.0 achieve similar predictive
performance, suggesting that NetChop C-term 3.0 has a
proteasomal cleavage signal with a quality that is
comparable to that of NetChop 20S-3.0, which has been
trained on in vitro cleavage data.
In Fig. 3, we compare the predictive performance of
the method of NetMHC, BIMAS, SYFPEITHI, and that of
the integrated method when evaluated on the SYF
2
dataset. Using the bootstrap analysis on the Arank
performance measure, we found that NetMHC performs
significantly better than SYFPEITHI (p<0.001), and
marginally better than the BIMAS method (p=0.05).
The integrated INT method has a performance on both
the AUC and Arank measures that is significantly higher
than that of the SYFPEITHI, BIMAS, and NetMHC
prediction methods (p<0.01 in all comparisons).
A direct measure of the performance gain when
comparing the integrated method to that of predicted
MHC affinity predictions alone is the rank value needed
to identify 85% of the epitopes in a dataset. For the SYF
2
dataset, this rank value is 23%, 12%, and 12% when
using the prediction methods of SYFPEITHI, BIMAS,and
NetMHC, respectively. For the integrated method, this
rank value is reduced to 8%. Evaluating the different
prediction methods on the largerSYF
1 dataset,we found
similar results. Here, the 85% coverage rank value for
the BIMAS, NetMHC and integrated method is 12%,
12%,and8%,respectively.Wedefinethetermreliability
of a prediction method as the probability of identifying
an epitope in a given protein within a certain top
percentage of the peptides. If a protein contains 300
nonameric peptides, 24, 36, 36 and 64 peptides must be
Fig. 3. AUC and Arank performance measures for the different
prediction methods evaluated on the SYF
2 dataset. The
methods included in the figure are; NetMHC: MHC class I
affinity by ANN, BIMAS and SYFPEITHI: Two publicly available
methods predicting MHC class I binding [22, 23], and INT: The
integrated method combining predictions of MHC class I
binding, TAP transport efficiency, and C-terminal proteasomal
cleavage.
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reliability, if using the integrated, NetMHC, BIMAS, and
SYFPEITHI prediction methods, respectively. Compared
to the BIMAS method, the integrated method will thus,
on average, lead to a reduction in the experimental
effort by more than 30%. If the experimental effort is
limited to the peptides predicted to be in the top 5%, the
reliability values for the integrated, NetMHC, BIMAS,
and SYFPEITHI methods, respectively, are 78%, 76%,
72%, and 69%.
Next, we repeated the analysis using the benchmark
data from the independent HIV dataset. The overall AUC
and Arank values of the analysis are visualized in Fig. 4.
The results confirm the findings from the SYF datasets
that the performance of the integrated method is
superior to that of the individual methods. We found
that the integrated method performs better than the
BIMAS and SYFPEITHI methods (p<0.025). The
number of peptides needed to be tested to reach 85%
reliability is 7%, 10%, and 9% for the integrated,
NetMHC, and BIMAS predictions, respectively, when
analyzing the complete HIV
1 dataset with 69 epitopes.
Looking at the reduced HIV
2 dataset and including the
SYFPEITHI prediction method, the corresponding
numbers are 7%, 9%, and 10% for the integrated,
BIMAS, and SYFPEITHI method, respectively. Finally,
we find that the reliability values when looking only at
the top-scoring 5% predictions are 77% (77%), 73%
(73%), and 72% for the integrated, BIMAS, and
SYFPEITHI methods, respectively. Here, the values in
parenthesis refer to the complete HIV
1 dataset. These
numbers thus support the results found when using the
SYF datasets.
Discussion
In this report, we have used an integrative approach to
improve CTL epitope identification. We have integrated
predictions of MHC class I binding affinity, TAP
transport efficiency, and C-terminal proteasomal clea-
vage, and demonstrated in a large-scale benchmark that
the integrated method has a predictive performance
significantly higher than any of the individual methods,
as well as the publicly available BIMAS and SYFPEITHI
prediction methods.
Other groups have previously combined different
prediction methods: Hakenberg et al. [24] developed a
bioinformatical tool for prediction of CTL epitopes by
combining predictions of proteasomal cleavage and
MHC class I affinity. On a very small dataset of only five
epitopes from HIV Nef, Kesmir et al. [17] showed that
combining predictions of proteasomal cleavage with
measured TAP and MHC class I binding affinity
correlates well with the observed number of MHC class
Iligandspresentedonthecell.Inanotherstudy,Peterset
al. [16] improved identification of epitopes by combin-
ing predictions of binding affinities to the HLA-A*0201
allele with predictions of TAP transport efficiency. They
also combined HLA-A*0201 affinity predictions with
predictions of C-terminal cleavages by NetChop 20S,
and showed that this lead to a less accurate identifica-
tion of epitopes.
In the present work, wehaveextended theanalysis of
Peters et al. to include epitopes from ten different MHC
class I supertypes spanning the large variation in MHC
class I specificity. Further, we have modeled the
proteasomal cleavage event by novel and more reliable
prediction algorithms [18]. Including a broad set of
MHC class I specificities in the analysis allows us to: (1)
draw more general and well-founded conclusions about
howtointegratethedifferentstepsintheclassIpathway
in the most optimal manner, and (2) derive a prediction
method that is broadly applicable for the identification
of CTL epitopes.
In designing the optimal prediction method, we
tested severalversionof the NetChopcleavagepredictor.
We found that the two NetChop methods trained on in
vitro digestion data on their own have the poorest
performance, followed by the two NetChop methods
trained on epitope data. However, when combining
cleavagepredictionswithaffinitytoMHCclassIandTAP
transport efficiency, all combinations achieve close to
identical performance. Concern has previously been
Fig. 4. Predictive performance for the different prediction
methods. Predictions are made on the two HIV datasets. AUC1
and Arank1 refer to the complete HIV
1 dataset, AUC2 and
Arank2 to the reduced HIV
2 dataset. The methods included in
the figure are: INT: The integrated method integrating predic-
tions of MHC class I binding TAP transport efficiency, and C-
terminal proteasomal cleavage, BIMAS and SYFPEITHI: Two
publicly available methods predicting MHC class I binding [22,
23].
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on natural MHC class I ligand data does not only predict
proteasomal cleavage, but rather a combination of
cleavage, TAP transport efficiency, and affinity to the
“average” MHC class I allele [16]. Here, we demonstrate
thatwhen predictingCTL epitopes, the NetChopmethod
trained on epitope data outperforms the methods
trained on in vitro degradation data. However, in
combinationwith MHC class I affinity and TAP transport
efficiency predictions both epitope and in vitro digest
trained methods show similar performance. Two con-
clusions can be drawn from this: (1) the high
performance of the NetChop method trained on epitope
data does not come from more accurate predictions of
the proteasomal cleavage event, but rather from indirect
integration of TAP transport efficiency and MHC class I
affinity, and (2) the proteasomal cleavage predicting
element of the NetChop method trained on epitope data
has a quality that is comparable to that of the method
trained on in vitro data. These observations leave,
however, promise for future improvements to CTL
epitope predictions, since it should be possible to
improve proteasomal predictions by developing a
method describing the specificity of the immuno-
proteasome and integrate it with NetChop 20S-3.0,
which predicts the constitutive proteasome cleavage
specificity.
We have validated the performance of the integrated
method on a setof known HIVepitopes derived from the
Los Alamos database. A direct implication of the
improved predictive performance of the integrated
method is a significant gain in sensitivity at 85%
reliability level. Using the integrated method, we thus
find that the experimental effort needed to reach 85%
reliability is significantly reduced as compared to
predictions based on MHC class I affinity alone (using
NetMHC, BIMAS, or SYFPEITHI prediction methods).
We believe that this improved identification of peptides
capable of eliciting a CTL response will be useful in
reverse immunogenetic approaches, and hence in the
process of rational vaccine design.
Materials and methods
Datasets
SYF dataset
On February 5, 2004, 779 nonameric peptides present in the
SYFPEITHI database (http://www.syfpeithi.de) [21] and
classified as either ligand for MHC class I (HLA-A or HLA-B)
or T cell epitope were extracted. To obtain the largest possible
set of data, we included peptides classified as Tcell epitopes in
the analyses, even though these peptides are not for certain
naturally processed. This we did at the risk of potentially
including a small set of misclassified data. Since the non-
natural pathway most likely does not share any of the
specificitiesof the classIpathway(except MHCclass Ibinding)
such data will lower the significance of our analyses. In the
SYFPEITHI database, it is stated that, “as far as Tcell epitopes
are concerned, only those have been selected which are likely
to be naturally processed”, and the potential number of false
classifications should hence be small. For every peptide, the
source protein was subsequently found in the SwissProt
database. If more than one protein was the possible origin of a
given peptide, a protein was chosen according to the following
criteria: It had to be either a human protein or a protein from a
human pathogen. If there were still more possible proteins, the
correct one was found by tracking the source of the peptide in
the SYFPEITHI database. The resulting dataset contained 663
peptides with corresponding source proteins. In Table 1, the
peptides have been grouped according to MHC class I allele,
and further grouped into one of the 12 MHC class I supertypes
[20]. Since we only have access to high accuracy prediction
methods for the 12 MHC class I supertypes, and their alleles,
peptides binding to alleles like HLA-A23, HLA-A2902, HLA-
B14, and HLA-B1516 that are not classified as belonging to any
of the supertypes were excluded from the study. Within each
supertype duplicate peptides were removed, leaving 567
peptides in the dataset. After removing the peptides that have
been used to train the MHC class I affinity-predictors or
NetChop C-term 2.0/3.0 prediction methods, 148 peptides
remained in the dataset. These peptides are referred to as the
epitopes of the SYF
1 dataset. SYFPEITHI [21] does not have
predictors for any alleles belonging to the supertypes B58 and
B62, and to be able to compare the performance against
SYFPEITHIpredictions,asubset(SYF
2)wasconstructedwhere
peptides restricted to alleles assigned to these supertypes were
excluded. This dataset contains 140 peptides.
HIV dataset
On May 12, 2004, 1005 nonameric peptides present in of the
HIV Immunology CTL database of the Los Alamos HIV
Database (www.hiv.lanl.gov) were collected. For the HIV
epitope data, we have no direct handle on whether a peptide
has been naturally processed or not. A non-naturally processed
epitopewill in the analysis appear as a false positive, and lower
the significance of our results. To achieve a large dataset we,
however, chose to include all peptides in the analysis. Peptides
known only to bind non-human MHC class I or binding an
unknownMHC class I allele were removed from the dataset.As
with the peptides in the SYF dataset, the peptides were
grouped according to MHC class I allele, and further grouped
into 1 of the 12 MHC class I supertypes. Peptides binding to
alleles that are not classified as belonging to any of the
supertypes wereexcludedfrom the study.Subsequently, allthe
peptides that have been used to train the MHC class I affinity-
predictors or NetChop C-term 2.0/3.0 were removed from the
set. The amino acid sequences of the 9 SwissProt entries from
taxon Human immunodeficiency virus type 1 (HXB2 isolate)
(HIV-1) were then collected, and only the 69 peptides
contained in one of these proteins were included in the final
dataset. These 69 peptides are referred to as the epitopes of
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1. To be able to compare the performance against
SYFPEITHIpredictions,asubset(HIV
2)wasconstructedwhere
peptides restricted to alleles assigned to the B58 and the B62
supertypes were excluded. The HIV
2 dataset contained 62
peptides. For both the SYF and HIV datasets all nonameric
peptides contained in the protein sequences from which the
epitopes originated, except those annotated as epitopes in
either the complete SYFPEITHI or Los Alamos HIV databases,
were taken as negative peptides and will be referred to as non-
epitopes. When using this definition of epitopes/non-epitopes
one has totake into account that some nonamers will falsely be
classified as non-epitopes because the SYFPEITHI and Los
Alamos HIV databases are incomplete. Since the MHC class I
molecules are very specific, binding only a highly limited
repertoire of peptides, this misclassified proportion will,
however, be very small. A given MHC class I molecule has a
specificity of *1% [1]. In a protein of 100 amino acids, one
expects to have 1 binding and approximately 99 non-binding
peptides. The potential number of false classifications is hence
orders of magnitude smaller than the actual number of
negatives. All datasets are available as complementary
material at http://www.cbs.dtu.dk/suppl/immunology/
CTL.php.
Predicting proteasomal cleavage patterns
The four prediction methods described below were used
individuallytoassignapredictedcleavagevaluetotheresidues
of the proteins in the SYF and HIV dataset. A low predicted
cleavage value corresponds toa low probability of proteasomal
cleavage, whereas a high value corresponds to a high
probability of cleavage.
The C-term 2.0 and 20S networks of the NetChop 2.0
prediction server (www.cbs.dtu.dk/services/NetChop): This is
a standard artificial feed-forward neural network (ANN) with
one hidden layer of units. C-term 2.0 is trained on publicly
available human MHC class I ligands. The C-terminal amino
acids of the ligands were classified as cleavage sites, whereas
sites within the ligands were labeled non-cleavage sites. 20S is
trained on constitutive proteasome in vitro digests of yeast
enolase and bovine-casein. For details on the dataset
construction and ANN training see [17].
The NetChop C-term 3.0 and NetChop 20S-3.0 prediction
servers (www.cbs.dtu.dk/services/NetChop-3.0): These ANNs
have been trained on the same data as the NetChop C-term 2.0
and NetChop 20S networks, using an optimized training
strategy and combinations of several ANNs each trained with
different types of sequence encodings. In a large-scale
benchmark calculation these new networks were shown to
have a predictive performance superior to that of both
NetChop and other public methods [18].
Table 1. Summary of alleles selected to represent the different supertypes
a)
Supertype Alleles included in supertype No of
9mers
b)
No of 9mers
not used for
training
c)
NetMHC BIMAS SYF
A1 A01, A3001, A3002, A3003, A3004 26 1 A0101 A1 A*01
A2 A0201, A0204, A0205, A0206, A0207, A0214,
A0217, A6901
172 39 A0201 A0201 A*0201
A3 A03, A0301, A1101, A3101, A3303, A6601,
A6801
56 25 A1101 A3 A*03
A24 A24, A2402, A2403 38 15 A2403 A24 A*2402
A26 A2601, A2602, A2603 5 – – –
B7 B07, B0702, B35, B3501, B3503, B5101, B5102,
B5103, B53, B5301, B5501, B5502, B5601
87 34 B0702 B7 B*0702
B8 B08, B0801, B0802 22 5 B0801 B8 B*08
B27 B1518, B27, B2701, B2702, B2703, B2704,
B2705, B2706, B7301
62 18 B2705 B2705 B*2705
B39 B1509, B1510, B3801, B3901, B3909 29 – – –
B44 B3701, B40, B40012, B4006, B44, B4402, B4403 20 3 B4001 B40 B*4402
B58 B1513, B1517, B5701, B5702, B5801, B5802 25 4 B5801 B5801 –
B62 B1501, B1502, B1503, B1508, B1512, B4601,
B5201
25 4 B1501 B62 –
TOTAL 67 (75) 567 148
a) The 12 supertypes and the alleles are classified as belonging to each supertype [20].
b) The number of unique nonamers in each group for which it was possible to locate a source protein in the SwissProt database.
c) The number of nonamers not included in training of NetMHC and NetChop C-term 2.0/3.0 predictors. The last three columns
summarize which NetMHC, BIMAS [22] and SYFPEITHI [23] methods are used to represent each supertype.
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The TAP transport efficiency prediction method is based on the
matrix described in Peters et al. [16]. Predicted TAP transport
efficiency of peptides with arbitrary length is calculated by
scoring only the C terminus and the three N-terminal residues.
The contribution of the N-terminal residues tothe final score is
down-weighted by a factor of 0.2 in comparison with the
contribution of the C terminus. The TAP transport efficiency
score for a given nonamer is given as the average of the values
for the nonamer and its decameric precursor. When using the
method, a low predicted value corresponds to a low TAP
transport efficiency, whereas a high predicted value corre-
sponds to a high TAP transport efficiency. Notice that in the
article by Peters et al. [16] the reverse situation applies, but we
have multiplied all numbers in the matrix by a factor of -1 to
facilitate the later combination of the TAP transport efficiency
withtheproteasomalcleavagepatternandMHCclassIbinding
affinity.
MHC class I affinity predictions
For the A1, A2, A3, A24, B7, B8, B27, B44, B58, and B62
supertype the affinity predictors are based on ANN [12, 13].
This prediction method is available at http://cbs.dtu.dk/
services/NetMHC. Each supertype is represented by an ANN
trained on nonameric peptides with known binding affinity to
agivenMHCclassIallele.Table1summarizeswhichallelesare
selected to represent the different supertypes. Predictors for
the A26 and B39 supertypes were not available, and peptides
binding alleles of either of these two supertypes were excluded
from the study. Each peptide is assigned a value between 0 and
1,where0correspondstolowMHCclassIaffinityand1tohigh
affinity [13]. When combining the predictions of MHC class I
affinity, TAP transport efficiency, and proteasomal cleavage,
the MHC class I affinities were rescaled to make the prediction
values comparable between MHC class I supertypes. Sturniolo
et al. [25] have outlined a simple approach to perform such a
rescaling: For each predictor, the MHC class I affinities for
500 000 random peptides were predicted and the 1% fractals
found. The rescaling is then performed by a simple division of
predicted MHC class I affinity by the 1% fractal for the
corresponding supertype. We shall refer to the ANN-based
MHC class I affinity prediction method as NetMHC. To validate
the predictive performance of the developed method, its
performance was compared to that of the BIMAS [22] and
SYFPEITHI [23] prediction methods. Table 1 summarizes
which prediction matrices were used for BIMAS and
SYFPEITHI for the different supertypes.
Performance measures
We applied a series of performance measures and statistical
tests to evaluate the predictive performance of the different
methods used in this study. When combining MHC class I
affinity predictions with predicted TAP transport efficiency
and C-terminal proteasomal cleavage, we applied two non-
parametric performance measures. One measure is the
conventional AUC value (the area under the ROC curve)
[26]. In this measure, all overlapping nonameric peptides in
the dataset are sorted according to the prediction score. The
epitopes define the positive set, whereas the negative set is
made up from the non-epitopes. In a typical calculation for the
SYF dataset for instance, the positive set contained 148
peptides, and the negative set more than 92 000 peptides. The
ROC curve is plotted from the sensitivity and 1-specificity
values calculated by varying the cut-off value (separating the
predicted positive from the predicted negative) from high to
low. The area under this curve gives the AUC value. The AUC
value is 0.5 for a random prediction method and 1.0 for a
perfect method. Even though commonly used, the AUC
measure is not easy to interpret intuitively. In the AUC
measure, all predictions are sorted in one pool. In situations
where the data consist of several proteins of very different
length, each with only one positive example, the longer
proteins will clearly contribute in a biased way to the AUC
measure. Here, we therefore designed a second performance
measure with a clearer and more intuitive interpretation. This
measure is a rank measure. For each protein in the benchmark,
we sorted all nonameric peptides based on the prediction
score. The rank value for the protein was calculated as the
percentage of non-epitope peptides with a score higher than
that of the corresponding epitope. From these rank values, we
constructed a rank curve showing the accumulative fraction of
proteins with a rank value below a certain value. From the
rank-curve, one can extract information on how large a
fraction of the proteins will have their epitopewithin top5% of
the predictions for instance. Finally, we defined a single
performance measure (Arank) as the area under the rank-
curve integrated from rank zero up to rank 50%. A perfect
prediction method will have all the epitopes at the top of the
sorted list with a rank of 0, and thus an Arank value of 1.0,
whereasapoor methodwillhavetheepitopesplacedrandomly
in the sorted list and hence have an Arank value of 0.25. The
Arank value is calculated for rank value up to 50% only, to
focusonthetoprankpartof thecurve.Amethodthatimproves
the rank position of an epitope within the top 50% is clearly
more relevant than a method improving the rank position in
the bottom end of the rank curve. Examples of ROC and rank-
curves are shown in Fig. 1. For both the AUC and Arank
performance measure, we were aware that some nonamers
will falsely be classified as non-epitopes because the
SYFPEITHI and Los Alamos HIV databases are incomplete.
The Bootstrap method used to test the significance of
a performance gain
We applied the Bootstrap method [27] to test the significance
of the difference in predictive performance between two
predictionmethods.InaBootstrapexperiment,wegenerateda
series of evaluation set replications by randomly drawing n
data points with replacement from the original dataset, where
n is the size of the original dataset. For each dataset replica, we
evaluated the predictive performance (AUC or Arank) of the
two methods, and the Bootstrap hypothesis test p value for the
hypothesis that method M1 performs better than method M2 is
estimated from the simple ratio #(M1<M2)/N, where
#(M1<M2) is the number of experiments where method
M2 outperformed method M1, and N the number of Bootstrap
Mette Voldby Larsen et al. Eur. J. Immunol. 2005. 35: 2295–2303 2302
f 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji.dereplica. A p value of 0.05 will indicate that method M1 is
performing significantly better than method M2.
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